Skip to content

Merchavia

  • HOME
  • COMPANY PROFILE
  • LIFE SCIENCE INVESMENTS
  • MEDICAL DISTRIBUTION
  • INVESTOR RELATIONS
  • MEDIA
  • CONTACT
  • HOME
  • COMPANY PROFILE
  • LIFE SCIENCE INVESMENTS
  • MEDICAL DISTRIBUTION
  • INVESTOR RELATIONS
  • MEDIA
  • CONTACT
Read more about the article Cardiacsence (about 5.67%) – completed the first phase of an experiment to measure respiratory rate
CARDIACSENSE

Cardiacsence (about 5.67%) – completed the first phase of an experiment to measure respiratory rate

  • Post published:13/10/2020
Read more about the article Astellas (about 0.6%) – announced the cancellation of the agreement with Juventas
JUVENTAS

Astellas (about 0.6%) – announced the cancellation of the agreement with Juventas

  • Post published:17/09/2020
Read more about the article Innovative Israeli Medical Devices in the UAE: The Cardiacsense Medical Watch for Identifying Arrythmia Will be Sold in the UAE
picture image

Innovative Israeli Medical Devices in the UAE: The Cardiacsense Medical Watch for Identifying Arrythmia Will be Sold in the UAE

  • Post published:15/09/2020
Read more about the article A Significant Vote of Confidence in Merchavia Holdings and Investments Ltd: More Investment House will lead a 4 million-shekel round of investment
picture image

A Significant Vote of Confidence in Merchavia Holdings and Investments Ltd: More Investment House will lead a 4 million-shekel round of investment

  • Post published:14/09/2020
Read more about the article Cardiacsense (5.67%), has signed an exclusive distribution agreement for the sale of medical watches in the UAE
CARDIACSENSE

Cardiacsense (5.67%), has signed an exclusive distribution agreement for the sale of medical watches in the UAE

  • Post published:14/09/2020
Read more about the article Calling of  Annual & special meeting for Oct 14, 2020
MERCHAVIA

Calling of Annual & special meeting for Oct 14, 2020

  • Post published:07/09/2020
Read more about the article Cardiacsense (about 5.67%) has signed an exclusive distribution agreement for the sale of medical watches in Switzerland
CARDIACSENSE

Cardiacsense (about 5.67%) has signed an exclusive distribution agreement for the sale of medical watches in Switzerland

  • Post published:07/09/2020
Read more about the article TrainPain (about 5.69%) – Beginning of an experiment for treatment using the AI-based digital platform
TRAINPAIN

TrainPain (about 5.69%) – Beginning of an experiment for treatment using the AI-based digital platform

  • Post published:31/08/2020
Read more about the article Invest $ 250,000 in Ora Smart as part of an investment round of $ 3m according to $ 10m (before) – following the reports
MERCHAVIA

Invest $ 250,000 in Ora Smart as part of an investment round of $ 3m according to $ 10m (before) – following the reports

  • Post published:30/08/2020
Read more about the article 2nd Quarter 2020
pdf1

2nd Quarter 2020

  • Post published:27/08/2020
← Newer Posts
Older Posts →

Investor Relations

  • Investors Lobby
  • Company Profile
  • Company Presentation
  • Immediate Reports
  • Financial Reports
  • Investors News
  • News in the Media
  • Management
  • Stock Chart
  • FAQ
  • Mail Alert
  • Contact

© all rights preserve to Merchavia LTD

HOME
COMPANY PROFILE
LIFE SCIENCE INVESMENTS
INVESTOR RELATIONS
Accessibility
CONTACT